Monday, January 5, 2015

The magnitude and impact of the medication non-adherence problem

Pin It Now!
We recently had the opportunity to sit down with Dr. Katrina Firlik, Co-Founder and Chief Medical Officer at HealthPrize Technology. In our conversation, she started out by sharing the impact medication non-adherence.

She explained:
Speaker Dr. Katrina Firlik
Medication non-adherence is one of the most significant problems in healthcare. What is interesting is that it is one of the largest problems in the public that people don’t actually even know about. 
In terms of economic cost, it’s been estimated that non-adherence is the driver of about $290 billion in otherwise avoidable medical spending. That’s due to complications that could have been avoided if the patient had taken their medications. 

From a pharmaceutical revenue standpoint, we estimated in a report we co-authored with Capgemini Consulting that it’s the source of about $564 billion a year globally in lost revenue. In the US about $188 billion. Those are just the economic numbers, obviously, but the more significant impact is the personal impact to patients in the form of poor outcomes, complications that could have been avoided, lost productivity and the like.

So, it’s a serious problem with serious implications really for every stakeholder in healthcare, but most importantly for patients.

Katrina also discussed what this impact has downstream in a patient's experience, the realization of the non-adherence on a broader level than patients and physicians, potential interventions and more.  Download the entire interview here.

Want to hear more from Katrina? She'll be joining us at ePharma this February for the presentation Improve Medication Adherence by Understanding What’s Actually Driving Non-Adherence.  The event will take place February 24-26, 2015.  As a reader of this blog, when you register to join us and mention code XP2006BL, you can save $100 off the current rate!
Post a Comment